Post Menopausal Vaginal Atrophy Market
(Albany, US) DelveInsight’s “Post Menopausal Vaginal Atrophy Market Insights, Epidemiology, and Market Forecast-2032” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Post menopausal vaginal atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key facts of the Post
Menopausal Vaginal Atrophy Market
- According
to the American Association of Family Physicians, up to 40 percent of
postmenopausal women have symptoms of atrophic vaginitis. While 15% of the
female population experiences symptoms of vaginal atrophy before
menopause.
- While
vaginal atrophy is common, only 20 to 25 percent of symptomatic women seek
medical attention from their doctor.
- European
Vulvovaginal Epidemiological Survey examined >2,000 postmenopausal
women. Symptoms of Vaginal Atrophy were detected in 90% of women.
According to the results of the survey, the quality of life in this group
of women was significantly lower in comparison to that of women of
postmenopausal age without symptoms of Vaginal Atrophy.
Request for Sample Report:
https://www.delveinsight.com/sample-request/postmenopausal-vaginal-atrophy-market
View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market
Key benefits of the Post
Menopausal Vaginal AtrophyMarket report:
- The
study provides a detailed review of Post Menopausal Vaginal Atrophy,
including its causes, signs and symptoms, pathophysiology, diagnosis, and
current treatments.
- Study
of the 7MM has offered comprehensive insight into the epidemiology and
management of Post Menopausal Vaginal Atrophy.
- Furthermore,
an all-inclusive description of both present and emergingPost Menopausal
Vaginal Atrophy treatments is offered, as well as an analysis of future
therapies that will have an influence on the current treatment landscape.
- The
research includes a full evaluation of the Post Menopausal Vaginal Atrophy
market, both historical and anticipated, as well as drug outreach in the
7MM population.
- By
understanding the trends defining and driving the worldwide Post
Menopausal Vaginal Atrophy market, the study gives you an advantage when
formulating business plans.
Post
Menopausal Vaginal Atrophy Overview
Postmenopausal atrophic vaginitis, or vaginal atrophy, is
the thinning of the walls of the vagina caused by decreased estrogen levels.
Without estrogen, vaginal tissue thins and dries out. It becomes less elastic,
more fragile, and more easily injured. This most commonly occurs after
menopause. Women with vaginal atrophy have a greater chance of chronic vaginal
infections and urinary function problems. It can also make sexual intercourse
painful. Symptoms can include: thinning of the vaginal walls, shortening and
tightening of the vaginal canal, lack of vaginal moisture, vaginal burning,
spotting after intercourse, discomfort or pain during intercourse, pain or
burning with urination, more frequent urinary tract infections, and/or urinary
incontinence.
Atrophic vaginitis increases a woman’s risk of contracting
vaginal infections. Atrophy causes changes in the acidic environment of the
vagina, making it easier for bacteria, yeast, and other organisms to thrive. It
also increases the risk of urinary system atrophy (genitourinary atrophy).
Symptoms associated with atrophy-related urinary tract problems include more
frequent or more urgent urination or a burning sensation during urination.
Postmenopausal atrophic vaginitis is often diagnosed through
a physical examination, pelvic examination, vaginal smear test, vaginal acidity
test, blood test and urine test. With treatment, it’s possible to improve your
vaginal health and your quality of life. Estrogen replacement therapy and
Over-the-counter moisturizers or water-based lubricants can help treat dryness.
View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market
Post
Menopausal Vaginal Atrophy Market
The report’s Post Menopausal Vaginal Atrophy market outlook
assists in developing a detailed understanding of historic, current, and
forecasted Post Menopausal Vaginal Atrophy market trends by analyzing the
impact of current Post Menopausal Vaginal Atrophy therapies on the market,
unmet needs, drivers and barriers, and demand for better technology. This
section examines the Post Menopausal Vaginal Atrophy market trend of each
marketed drug and late stage pipeline therapy by evaluating their impact based
on the annual cost of therapy, inclusion and exclusion criteria, mechanism of
action, compliance rate, growing market need, increasing patient pool, covered
patient segment, expected launch year, competition with other therapies, brand
value, market impact, and key opinion leaders’ perspectives. Post Menopausal
Vaginal Atrophy market statistics are supplied with pertinent tables and graphs
to provide a comprehensive picture of the market at a glance. According to
DelveInsight, the Post Menopausal Vaginal Atrophy market in 7MM is expected to
undergo significant change between 2019 and 2032.
Learn more by requesting for sample @ Post
Menopausal Vaginal Atrophy Market Landscape
Post
Menopausal Vaginal Atrophy Companies
- Novo
Nordisk A/S
- PepTonic
Medical AB
- Pharma
Consulting Group AB
- Italfarmaco
S.A
- And
Many More
View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market
Post
Menopausal Vaginal Atrophy Pipeline
- Estradiol
- Estriol
- Oxytocin
- And
Many More
Know more about the pipeline therapies and recent
developments @ Post
Menopausal Vaginal Atrophy Pipeline Report
Table of Contents
- Key
Insights
- Executive
Summary of Postmenopausal Vaginal Atrophy
- Competitive
Intelligence Analysis for Postmenopausal Vaginal Atrophy
- Postmenopausal
Vaginal Atrophy: Market Overview at a Glance
- Postmenopausal
Vaginal Atrophy: Disease Background and Overview
- Patient
Journey
- Postmenopausal
Vaginal Atrophy Epidemiology and Patient Population
- Treatment
Algorithm, Current Treatment, and Medical Practices
- Postmenopausal
Vaginal Atrophy Unmet Needs
- Key
Endpoints of Postmenopausal Vaginal Atrophy Treatment
- Postmenopausal
Vaginal Atrophy Marketed Products
- Postmenopausal
Vaginal Atrophy Emerging Therapies
- Postmenopausal
Vaginal Atrophy: Seven Major Market Analysis
- Attribute
analysis
- 7MM:
Market Outlook
- Access
and Reimbursement Overview of Postmenopausal Vaginal Atrophy
- KOL
Views
- Market
Drivers
- Market
Barriers
- Appendix
- DelveInsight
Capabilities
- Disclaimer
- About
DelveInsight
Click here to read more about Post
Menopausal Vaginal Atrophy Market Outlook 2032
Related Reports by DelveInsight:
- Postmenopausal
Vaginal Atrophy Epidemiology
- Postmenopausal
Vaginal Atrophy Pipeline
- Post
Menopausal Osteoporosis Epidemiology
- Post
Menopausal Osteoporosis Pipeline
Other Reports:
- Thymic
Carcinoma Market
- Asphyxia
Market
- Acute
Agitation And Aggression Market
- HPV-Induced
Cancers Market
- Diagnostic
Imaging Equipment Market
- Epilepsy
Market
- Bradykinesia
Market
- Immunologic
Deficiency Syndrome Market
- Wilms
Tumor Market
- Advanced
Wound Care Market
- Defibrillators
Market
- Diagnostic
Imaging Equipment Market
- Pulse
Oximeters Market
- Achromatopsia
Market
- Cataplexy
Market
- Contusion
Market
- Fibrocystic
Breast Condition Market
- Aicardi
Goutieres Syndrome Market
- Acute
Gout Flare Market
- Acute
Ischemic Stroke Ais Market
- Menorrhagia
Market
- Opioid
Induced Constipation Market
- Osteosarcoma
Market
- Pruritus
Market
- Heavy
Metal Poisoning Market
- Acute
Lung Injury Market
- Intravenous
Immunoglobulin Market
- Scleroderma
Market
- Centronuclear
Myopathy Market
- Alstrom
Syndrome Market
- Neuroprosthetics
Market
- Airway
Stent Market
- Chronic
Rhinosinusitis Phenotype with Nasal Polyps Market
- Atrophic
Vaginitis Market
- Renal
Tubular Acidosis Market
- Advanced
liver cancer Market
Related Blogs:
- Most
Promising Applications of Artificial Intelligence (AI) in Healthcare
Segment
- Mapping
the Biggest Pharmaceutical Companies by Continents
- Widespread
Usage of HPV Vaccine Reduces Cervical Cancers and Precancers
- Major
Drugs Decisions for Cardiovascular Diseases to Watch Through 2022
- Assessment
of Key Products that Got FDA Approval in Second Half (H2) of 2021
- Evaluation
of Rapidly Evolving Parkinson’s Disease Therapeutic Market
- Cybersecurity
in Healthcare: Major Threats and Challenges
- Top
Drugs To Watch in HIV (2025)
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports Pharma
companies by providing comprehensive end-to-end solutions to improve their
performance. It also offers Healthcare Consulting Services, which benefits in
market analysis to accelerate the business growth and overcome challenges with
a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shambhavi Verma
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
Comments
Post a Comment